Related Experiment Video
Updated: Jun 10, 2026
09:02
Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
Published on: September 27, 2024
Liposomal contrast agents in brain tumor imaging.
Ketan B Ghaghada1, Rivka R Colen, Catherine R Hawley
1School of Health Information Sciences, The University of Texas Health Science Center at Houston, 7000 Fannin Street, Suite 600, Houston, TX 77030, USA.
Neuroimaging Clinics of North America
|August 17, 2010
Summary
Glioblastoma treatment is challenging. Nanoparticle liposomes show promise as carriers for brain tumor imaging and drug delivery, advancing nanomedicine applications.
Area of Science:
- Nanomedicine
- Oncology
- Biotechnology
Background:
- Glioblastoma multiforme treatment remains difficult despite conventional therapies.
- Nanomedicine offers potential advancements for brain tumor diagnosis and management.
- Liposomes are a key class of nanoparticles investigated for therapeutic and diagnostic applications.
Purpose of the Study:
- To review recent progress in liposome design for brain tumor applications.
- To highlight the functional characteristics of liposomes in neuro-oncology.
- To discuss the role of liposomes in brain tumor imaging.
Main Methods:
- Review of scientific literature on liposome technology and brain tumors.
- Analysis of nanoparticle design principles for targeted delivery.
- Evaluation of liposome-based contrast agents for imaging.
Main Results:
- Liposomes demonstrate versatility as nanocarriers for therapeutics and imaging agents.
- Advances in liposome design enhance their potential for brain tumor treatment.
- Functionalized liposomes show promise for improved brain tumor visualization.
Conclusions:
- Liposomes are a significant tool in nanomedicine for addressing glioblastoma.
- Further development of liposome-based strategies is crucial for advancing brain tumor imaging.
- Liposomes hold potential for integrated diagnostic and therapeutic approaches in neuro-oncology.
